Fever
Also known as: Pyrexia
Methodology & AI Transparency ⓘ
Fever Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: A fever is a body temperature that is higher than normal.
- 2 Real-world patient consensus: Diagnostic registry R50.9: Fever is managed within Blood Pressure (aka Pyrexia).
- 3 Typical cash cost range: Primary evaluation for Fever incorporates renal-electrolyte panels [Fever R50.9] and symptom diary review.
- 4 Top reported side effects / signs: Key Blood Pressure biomarkers for Fever (R50.9): Ankle-Brachial Index (ABI) [Fever R50.9] & Serum Creatinine & in Fever (R50.9: Potassium) (K+ 4.0 – 4.8 mEq/L (R50.9)).
Ask our AI Specialists anything about Fever
What Is Fever?
A fever is a body temperature that is higher than normal. A normal temperature can vary from person to person, but it is usually around 98.6 °F (37 °C). A fever is not a disease. It is usually a sign that your body is trying to fight an illness or infection. Infections cause most fevers. You get a fever because your body is trying to kill the virus or bacteria that caused the infection. Most of those bacteria and viruses do well when your body is at your normal temperature. But if you have a fever, it is harder for them to survive. Fever also activates your body's immune system.
Pathophysiology, Underlying Causes & Clinical Presentation
Biological expression of Fever (R50.9, Blood Pressure) reflects arterial smooth-muscle hypertrophy [Fever R50.9]. Cross-referenced with NIH MeSH (Fever), longitudinal control is benchmarked via Ankle-Brachial Index (ABI) [Fever R50.9].
Common Symptoms & Clinical Signs
- • Medicines, including some antibiotics , blood pressure medicines , and anti-seizure medicines
- • Autoimmune diseases
- • Presentation of Fever (R50.9): cold distal extremities in Fever (R50.9: or diminished peripheral)
- • Secondary Fever clinical sign: persistently elevated home in Fever (R50.9: or clinic blood)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Fever Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | R50.9 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | High Blood Pressure & Vascular Health | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Ankle-Brachial Index (ABI) [Fever R50.9] | 1.00 – 1.30 (R50.9) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Serum Creatinine & in Fever (R50.9: Potassium) | K+ 4.0 – 4.8 mEq/L (R50.9) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Urine Albumin-to-Creatinine Ratio [Fever R50.9] | < 15 mg/g (R50.9) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Fever
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Diphenhydramine Histaprin, Nightime Sleep Aid • RxCUI 1049630 | Histamine-1 Receptor Antagonist | 94% | $0.0159 | $ 5.27 /mo |
| Chlorpheniramine Maleate, Ibuprofen, Phenylephrine Hydrochloride Advil Allergy and Congestion Relief • RxCUI 1310503 | Nonsteroidal Anti-inflammatory Drug | 93% | $2.0200 | $ 90.31 /mo |
| Mometasone Furoate Monohydrate Allergy, Allergy Nasal • RxCUI 1797865 | Corticosteroid | 88% | $1.5635 | $ 12.88 /mo |
| Acetaminophen, Phenylephrine HCl Sinus and Headache, Sinus Congestion and Pain Relief Non-Drowsy • RxCUI 1046378 | alpha-1 Adrenergic Agonist | 93% | $0.0194 | $ 9.29 /mo |
| Calmour Childrens Acetaminophen Strips Chewable (Acetaminophen Oral Chewable 80 Mg) Calmour Childrens Acetaminophen Strips Chewable • RxCUI 2705808 | Over-the-Counter Clinical Monograph | 89% | $0.0194 | $ 9.90 /mo |
| Cold Sore Fever Blister Treatment (Docosanol) Cold Sore Fever Blister Treatment • RxCUI 797534 | Over-the-Counter Clinical Monograph | 94% | $6.6445 | $ 486.90 /mo |
| Loratadine Allergy Relief, Non Drowsy Allergy Relief • RxCUI 692783 | Allergies Agent | 81% | $0.0393 | $ 5.69 /mo |
| Acetaminophen, Guaifenesin, and Phenylephrine Hydrochloride Tylenol Sinus Severe, Lil Drug Store, Head Congestion Plus Mucus Pe • RxCUI 1243679 | Expectorant | 89% | $0.0194 | $ 9.29 /mo |
| Fexofenadine HCl Childrens Allergy, Allergy Relief • RxCUI 997491 | Histamine-1 Receptor Antagonist | 82% | $0.1512 | $ 9.05 /mo |
| Cetirizine HCl Allergy Relief, Childrens 24 Hour Allergy • RxCUI 1014675 | Histamine-1 Receptor Antagonist | 90% | $0.0216 | $ 5.45 /mo |
| Fexofenadine Hydrochloride Allergy Relief, Cabinet Allergy Relief Fexofenadine • RxCUI 997420 | Histamine-1 Receptor Antagonist | 79% | $0.2703 | $ 9.05 /mo |
| Diphenhydramine HCl Allergy Relief, Sleep Aid • RxCUI 1049909 | Histamine-1 Receptor Antagonist | 79% | $0.0275 | $ 5.27 /mo |
| Allergena Texas Cedar Fever Tabs (Allergy Relief) Allergena Texas Cedar Fever Tabs • RxCUI RXN-B62713956 | Non-Standardized Pollen Allergenic Extract | 87% | $0.0554 | $ 12.49 /mo |
| Loratadine Oral Claritin • RxCUI 311372 | Allergies Agent | 89% | $0.0393 | $ 5.69 /mo |
| Acetaminophen, Guaifenesin and Phenylephrine HCl Sinus Congestion and Pain Severe, Sinus Congestion and Pain • RxCUI RXN-49035527-2108 | Expectorant | 88% | $0.0194 | $ 9.29 /mo |
| Childrens Pain and Fever (Acetaminophen) Childrens Pain and Fever • RxCUI 307668-B42507148 | Over-the-Counter Clinical Monograph | 74% | $0.0194 | $ 9.90 /mo |
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Fever)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Long- and Intermediate-Acting Dihydropyridine Calcium Channel Blockers in high: What a 80,483-Participant Study Found This study suggests that Amlodipine offers greater protection against major complications of high blood pressure compared to intermediate-acting dihydropyridine calcium channel blockers. Journal of cardiovascular pharmacology and therapeutics • 2018-09-15 • Meta-Analysis | N = 80,483 | 94/100 | PMID 29739234 ↗ |
| New Insights on Benefits and safety of moderate-intensity rosuvastatin plus ezetimibe versus: What a 24,592-Participant Study Found Moderate-intensity statin plus ezetimibe with combination therapy had better real-world benefits and safety than high-intensity statins. PloS one • 2024-01-15 • Meta-Analysis | N = 24,592 | 94/100 | PMID 39536001 ↗ |
| New Insights on Immunogenicity and safety of concomitant and sequential administration of yellow: What a 900-Participant Study Found In this study, YF-17D vaccine and TAK-003 were immunogenic and well tolerated when sequentially or concomitantly administered. PLoS neglected tropical diseases • 2023-03-15 • Phase III Randomized Trial | N = 900 | 93/100 | PMID 36888687 ↗ |
| Can This Approach Help? Inside the Latest Research on Operational challenges and lessons learned from conducting febrile surveillance The design of the febrile surveillance protocol ensured high compliance in the trial. Travel medicine and infectious disease • 2025-01-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 40120920 ↗ |
| Can This Approach Help? Inside the Latest Research on Role of Serum Free Fatty Acids in Endothelium-Dependent Microvascular Short-term reduction of FFA concentration does not improve insulin-stimulated vasodilation in patients with metabolic syndrome. Endocrinology, diabetes & metabolism • 2025-03-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 39888728 ↗ |
Fever Patient Community & “People Like Me” Threads
Filter Fever community threads and patient logs by age, biological sex, dosage, and treatment duration.